Compassionate use and expanded access
License from Biocon
“On October 1, 2019, we entered into a Contract Transfer and License Agreement, or the Biocon Agreement, with Biocon Limited, or Biocon.” (opens the source at this quote in a new tab)
“Pursuant to the Biocon Agreement, we and Biocon agreed that Biocon would grant us a license, with the right to grant and authorize sublicenses to make, use, sell, offer to sell, import, and otherwise exploit certain fusion protein products of which ficerafusp alfa was the most advanced program.” (opens the source at this quote in a new tab)
Commercial distribution arrangements and patient assistance
No evidence found.